Successful Combination of Olaparib and 225Ac-Dotatate in a Patient with Neuroendocrine Tumor G3 and BRCA Mutation. [PDF]
Kröcher A +6 more
europepmc +1 more source
Impact of Germline <i>BRCA</i> Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis. [PDF]
Lee L +9 more
europepmc +1 more source
Decision aids for female BRCA mutation carriers: a scoping review. [PDF]
McGarrigle SA +9 more
europepmc +1 more source
Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation. [PDF]
Salfi G +17 more
europepmc +1 more source
The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer. [PDF]
Kim JH +12 more
europepmc +1 more source
Cost-utility analysis of olaparib assisted targeted therapy for BRCA mutation HER2-negative early breast cancer in China and in the United States. [PDF]
Xu C +5 more
europepmc +1 more source
Breast-Conserving Surgery in <i>BRCA</i> Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care. [PDF]
Cipolla C +8 more
europepmc +1 more source
Olaparib and somatic BRCA mutations
George, A, Banerjee, S, Kaye, S
openaire +2 more sources

